The Valley Desk

NCT03920007 · Interventional trial

Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions LCA, LCA1, Leber Congenital Amaurosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov